iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionHCR Wealth Advisors
Latest Disclosed Ownership2,712 shares
Latest Disclosed Value $ 458,052
HCR Wealth Advisors ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On April 21, 2026 - HCR Wealth Advisors filed a 13F-HR form disclosing ownership of 2,712 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $458,052 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 2,712 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $355,408 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F iShares Biotechnology ETF ETF 464287556 2,712 0 0.00 458 0.22 0.0475
2026-01-27 2025-12-31 13F iShares Biotechnology ETF ETF 464287556 2,712 3 0.11 458 12.84 0.0453
2025-10-03 2025-09-30 13F iShares Biotechnology ETF ETF 464287556 2,709 -290 -9.67 405 6.86 0.0420
2025-07-17 2025-06-30 13F iShares Biotechnology ETF ETF 464287556 2,999 -62 -2.03 379 -3.07 0.0447
2025-04-21 2025-03-31 13F iShares Biotechnology ETF ETF 464287556 3,061 0 0.00 392 -3.22 0.0510
2025-01-14 2024-12-31 13F iShares Biotechnology ETF ETF 464287556 3,061 -7,645 -71.41 405 -74.07 0.0507
2024-10-10 2024-09-30 13F iShares Biotechnology ETF ETF 464287556 10,706 -2,747 -20.42 1,559 -15.60 0.2040
2024-08-07 2024-06-30 13F iShares Biotechnology ETF ETF 464287556 13,453 83 0.62 1,847 0.65 0.2639
2024-05-10 2024-03-31 13F iShares Biotechnology ETF ETF 464287556 13,370 -724 -5.14 1,835 -4.18 0.2782
2024-02-09 2023-12-31 13F iShares Biotechnology ETF ETF 464287556 14,094 -803 -5.39 1,915 5.11 0.3024
2023-10-20 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,897 -5,377 -26.52 1,822 -29.23 0.3994
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 20,274 14,624 258.83 2,574 252.95 0.4767
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,650 -200 -3.42 730 -4.95 0.1444
2023-02-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,850 -133 -2.22 768 9.57 0.1612
2022-11-07 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,983 -570 -8.70 700 -9.21 0.1487
2022-08-12 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,553 -2,535 -27.89 771 -34.88 0.1548
2022-05-05 2022-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,088 -29,426 -76.40 1,184 -79.86 0.1935
2022-02-04 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 38,514 278 0.73 5,878 -4.92 0.9111
2021-11-02 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 38,236 181 0.48 6,182 -0.74 1.0316
2021-07-21 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 38,055 811 2.18 6,228 11.06 1.0812
2021-05-13 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 37,244 -560 -1.48 5,608 -2.08 1.1088
2021-02-04 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 37,804 2,041 5.71 5,727 18.23 1.1986
2020-11-05 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 35,763 32,909 1,153.08 4,844 1,135.71 1.1075
2020-07-30 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,854 1,724 152.57 392 221.31 0.0920
2020-05-08 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,130 50 4.63 122 -6.15 0.0349
2020-02-07 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,080 1,080 130 0.0315
2019-05-10 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -6,503 -100.00 0 -100.00
2019-01-31 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 6,503 -49 -0.75 627 -13.99 0.2026
2018-11-08 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 6,552 -521 -7.37 729 -7.13 0.2375
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 7,073 -800 -10.16 785 -6.55 0.2576
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,873 -200 -2.48 840 -2.55 0.2913
2018-02-13 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,073 5,402 202.25 862 -3.25 0.3011
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,671 260 10.78 891 19.12 0.3750
2017-08-16 2017-06-30 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 2,411 610 33.87 748 41.67 0.3694
2017-05-11 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,801 -60 -3.22 528 6.88 0.2705
2017-02-14 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,861 1,861 494 0.2610
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.